362 related articles for article (PubMed ID: 17939047)
21. The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
Fimiani B; Guardia DD; Puoti C; D'Adamo G; Cioffi O; Pagano A; Tagliamonte MR; Izzi A
Eur J Intern Med; 2011 Dec; 22(6):587-90. PubMed ID: 22075285
[TBL] [Abstract][Full Text] [Related]
22. High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome.
Hinz M; Wree A; Jochum C; Bechmann LP; Saner F; Gerbes AL; Gerken G; Canbay A
Ann Hepatol; 2013; 12(1):92-9. PubMed ID: 23293199
[TBL] [Abstract][Full Text] [Related]
23. Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome.
Wong F; Pappas SC; Boyer TD; Sanyal AJ; Bajaj JS; Escalante S; Jamil K;
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):266-272.e1. PubMed ID: 27464593
[TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial.
Solanki P; Chawla A; Garg R; Gupta R; Jain M; Sarin SK
J Gastroenterol Hepatol; 2003 Feb; 18(2):152-6. PubMed ID: 12542598
[TBL] [Abstract][Full Text] [Related]
25. Poor outcomes with treatment of hepatorenal syndrome type 1 with splanchnic vasoconstrictors and albumin: report of seven cases and review of the literature.
Kalil JR; Cerqueira LA; Barbosa DS; Motta MP; Nery Mda S; Bittencourt PL
Arq Gastroenterol; 2009; 46(3):214-8. PubMed ID: 19918689
[TBL] [Abstract][Full Text] [Related]
26. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.
Moreau R; Durand F; Poynard T; Duhamel C; Cervoni JP; Ichaï P; Abergel A; Halimi C; Pauwels M; Bronowicki JP; Giostra E; Fleurot C; Gurnot D; Nouel O; Renard P; Rivoal M; Blanc P; Coumaros D; Ducloux S; Levy S; Pariente A; Perarnau JM; Roche J; Scribe-Outtas M; Valla D; Bernard B; Samuel D; Butel J; Hadengue A; Platek A; Lebrec D; Cadranel JF
Gastroenterology; 2002 Apr; 122(4):923-30. PubMed ID: 11910344
[TBL] [Abstract][Full Text] [Related]
27. Terlipressin therapy for renal failure in cirrhosis.
Triantos CK; Samonakis D; Thalheimer U; Cholongitas E; Senzolo M; Marelli L; Leandro G; Patch D; Burroughs AK
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):481-6. PubMed ID: 19952764
[TBL] [Abstract][Full Text] [Related]
28. Noradrenaline is as Effective as Terlipressin in Hepatorenal Syndrome Type 1: A Prospective, Randomized Trial.
Goyal O; Sidhu SS; Sehgal N; Puri S
J Assoc Physicians India; 2016 Sep; 64(9):30-35. PubMed ID: 27762512
[TBL] [Abstract][Full Text] [Related]
29. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
von Kalckreuth V; Glowa F; Geibler M; Lohse AW; Denzer UW
Z Gastroenterol; 2009 Jan; 47(1):21-6. PubMed ID: 19156588
[TBL] [Abstract][Full Text] [Related]
30. Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.
Cavallin M; Kamath PS; Merli M; Fasolato S; Toniutto P; Salerno F; Bernardi M; Romanelli RG; Colletta C; Salinas F; Di Giacomo A; Ridola L; Fornasiere E; Caraceni P; Morando F; Piano S; Gatta A; Angeli P;
Hepatology; 2015 Aug; 62(2):567-74. PubMed ID: 25644760
[TBL] [Abstract][Full Text] [Related]
31. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
Uriz J; Ginès P; Cárdenas A; Sort P; Jiménez W; Salmerón JM; Bataller R; Mas A; Navasa M; Arroyo V; Rodés J
J Hepatol; 2000 Jul; 33(1):43-8. PubMed ID: 10905585
[TBL] [Abstract][Full Text] [Related]
32. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.
Nazar A; Pereira GH; Guevara M; Martín-Llahi M; Pepin MN; Marinelli M; Solá E; Baccaro ME; Terra C; Arroyo V; Ginès P
Hepatology; 2010 Jan; 51(1):219-26. PubMed ID: 19877168
[TBL] [Abstract][Full Text] [Related]
33. Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.
Ghosh S; Choudhary NS; Sharma AK; Singh B; Kumar P; Agarwal R; Sharma N; Bhalla A; Chawla YK; Singh V
Liver Int; 2013 Sep; 33(8):1187-93. PubMed ID: 23601499
[TBL] [Abstract][Full Text] [Related]
34. Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
Kim HR; Lee YS; Yim HJ; Lee HJ; Ryu JY; Lee HJ; Yoon EL; Lee SJ; Hyun JJ; Jung SW; Koo JS; Choung RS; Lee SW; Choi JH
Clin Mol Hepatol; 2013 Dec; 19(4):417-20. PubMed ID: 24459647
[TBL] [Abstract][Full Text] [Related]
35. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.
Rodríguez E; Elia C; Solà E; Barreto R; Graupera I; Andrealli A; Pereira G; Poca M; Sánchez J; Guevara M; Soriano G; Alessandria C; Fernández J; Arroyo V; Ginès P
J Hepatol; 2014 May; 60(5):955-61. PubMed ID: 24447876
[TBL] [Abstract][Full Text] [Related]
36. Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function.
Huang X; Bindra J; Chopra I; Niewoehner J; Wan GJ
Adv Ther; 2023 Dec; 40(12):5432-5446. PubMed ID: 37812332
[TBL] [Abstract][Full Text] [Related]
37. Hepatorenal syndrome in patients with cirrhosis.
Moreau R
J Gastroenterol Hepatol; 2002 Jul; 17(7):739-47. PubMed ID: 12121502
[TBL] [Abstract][Full Text] [Related]
38. Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin.
Weinberg EM; Wong F; Vargas HE; Curry MP; Jamil K; Pappas SC; Sharma P; Reddy KR
Liver Transpl; 2024 Apr; 30(4):347-355. PubMed ID: 37801553
[TBL] [Abstract][Full Text] [Related]
39. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
Testro AG; Angus PW
J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
[No Abstract] [Full Text] [Related]
40. Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome.
Kalambokis GN; Pappas K; Tsianos EV
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):434-7. PubMed ID: 22893473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]